WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
- the formation of new blood vessels
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 血管新生阻害剤の概要 overview of angiogenesis inhibitors
- 2. 難治性狭心症マネージメントのための血管新生療法 therapeutic angiogenesis for management of refractory angina
- 3. ER／PR陰性、HER2陰性（トリプルネガティブ）乳癌の疫学、危険因子および臨床的アプローチ epidemiology risk factors and the clinical approach to er pr negative her2 negative triple negative breast cancer
- 4. 上皮性卵巣癌、卵管癌、 または腹膜癌における血管新生阻害剤の作用 the role of angiogenesis inhibitors in epithelial carcinoma of the ovary fallopian tube or peritoneum
- 5. 下肢の慢性重症下肢虚血の治療 treatment of chronic lower extremity critical limb ischemia
English Journal
- Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1).
- Shanab AY1, Elshaer SL, El-Azab MF, Soliman S, Sabbineni H, Matragoon S, Fagan SC, El-Remessy AB.
- Angiogenesis.Angiogenesis.2015 Apr;18(2):137-50. doi: 10.1007/s10456-014-9451-4. Epub 2014 Nov 25.
- Ischemic diseases such as stroke and proliferative retinopathy are characterized by hypoxia-driven release of angiogenic factors such as vascular endothelial growth factor (VEGF). However, revascularization of the ischemic areas is inadequate, resulting in impaired neuro-vascular function. We aim to
- PMID 25420481
- Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment.
- Han J, Guo J1.
- Current molecular medicine.Curr Mol Med.2015;15(5):446-55.
- Cervical cancer is the second leading gynecological malignancy threat to the health of women in the world. However, few improvements in the efficacy of treatments of cervical cancer have been reported for the recurrent and metastasis patterns. As an endogenous antitumor agent, pigment epithelium der
- PMID 26122658
- Snake venom derived molecules in tumor angiogenesis and its application in cancer therapy; an overview.
- Dhananjaya BL, Sivashankari PR1.
- Current topics in medicinal chemistry.Curr Top Med Chem.2015;15(7):649-57.
- Snake venom is a complex mixture of biologically and pharmacologically active components, comprising hydrolytic enzymes, non-enzymatic proteins/peptides, and small amounts of organic and inorganic molecules. The venom components are known to vary with geographic location, season, species and age of
- PMID 25714377
Related Links
- 英語をクリック → Angiogenesis Modulating Agent との組み合わせでEntrez を検索 トロンボスポンジン1 (Thrombospondin 1); トロンボスポンジン (Thrombospondin); 生理的血管新生 (Physiologic Neovascularization); 絨毛尿膜 ); 血管内皮 ...
- Definitions of angiogenesis modulating agents, synonyms, antonyms, derivatives of angiogenesis modulating agents, analogical dictionary of angiogenesis modulating agents (English) Français Español Português English ...
Related Pictures
★リンクテーブル★
| リンク元 | 「血管新生調節剤」「血管新生調節薬」 |
| 関連記事 | 「agent」「age」 |
「血管新生調節剤」
「血管新生調節薬」
「agent」
- n.
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
「age」
- n.
- 年齢、歳
- v.
- 加齢する、熟成する